JMPWA
ALDX icon

JP Morgan Private Wealth Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100,111
Closed -$840K – 1714
2023
Q2 		$840K Buy
+100,111
New +$986K ﹤0.01% 819

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ALDX Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors sold out of Aldeyra Therapeutics (ALDX) in Q3 2023, closing a stake of 100,111 shares — an estimated $840K sold.

JP Morgan Private Wealth Advisors first reported a position in ALDX in Q2 2023 and held it in 1 quarter. The position peaked at $840K in Q2 2023. 120 funds tracked by Wall St. Rank hold ALDX as of Q3 2023.

  • JP Morgan Private Wealth Advisors reported no remaining Aldeyra Therapeutics position as of Q3 2023 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 100,111 Aldeyra Therapeutics shares in Q3 2023, an estimated $840K.
  • JP Morgan Private Wealth Advisors first reported a position in Aldeyra Therapeutics in Q2 2023 and held it in 1 quarter.
  • JP Morgan Private Wealth Advisors's Aldeyra Therapeutics position peaked at $840K in Q2 2023.
  • 120 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.